# naproxen sodium pm

NDC: 41250-526
Generic name: diphenhydramine hydrochloride, naproxen sodium
Labeler / Manufacturer: Meijer Distribution Inc
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200114

FDA application: ANDA208499

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"41250-526"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=41250-526
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=34d635f8-9703-4c29-92a5-85d3b47c4c93